|
Generic Name : Repaglinide
Pronunciation : re-PAG-li-nide
Therapeutic Classification : antidiabetics
Trade Name(s):
India- Eurepa, Novonorm, Page, Q-Repa, Rapilin, Regan, Repa, Repide, Restrict. International- Prandin. When it is not to be taken (Contraindications): Contraindicated in patients with diabetic ketoacidosis, with or without coma, type 1 diabetes, co-administration with gemfibrozil, and known hypersensitivity.
When it is to be taken : Adults- PO- The recommended initial dose is 0.5 mg with each meal. How it should be taken : It comes as a tablet to take by mouth, with food. Special Instruction : * Caution should be exercised in patients with history of adrenal, pituitary, liver, or kidney problems, high blood acid levels, high fever, poor nutrition, alcoholism, severe infection, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding. * It may cause dizziness, do not drive a car or operate machinery while taking this medication. * Avoid alcohol consumption. * Monitor fasting blood sugar and hemoglobin A1c level regularly while taking this medication. Side Effects : Metabolic - Decrease in blood sugar. Respiratory - Upper respiratory tract infection and inflammation of sinus/nose/lungs. Gastrointestinal - Nausea, diarrhea, constipation, vomiting, and indigestion. Musculoskeletal - Joint pain and back pain. Other - Headache, tingling, chest pain, urinary tract infection, tooth disorder and allergy. * Avoid excess dosage. Storage Conditions : Store it at controlled room temperature (25°C), and in an airtight container. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


